The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
Open accessAbstract
Cancer and cardiovascular (CV) disease are the most prevalent diseases in the developed world. Evidence increasingly shows that these conditions are interlinked through common risk factors, coincident in an ageing population, and are connected biologically through some deleterious effects of anticancer treatment on CV health. Anticancer therapies can cause a wide spectrum of short- and long-term cardiotoxic effects. An explosion of novel cancer therapies has revolutionised this field and dramatically altered cancer prognosis. Nevertheless, these new therapies have introduced unexpected CV complications beyond heart failure. Common CV toxicities related to cancer therapy are defined, along with suggested strategies for prevention, detection and treatment. This ESMO consensus article proposes to define CV toxicities related to cancer or its therapies and provide guidance regarding prevention, screening, monitoring and treatment of CV toxicity. The majority of anticancer therapies are associated with some CV toxicity, ranging from asymptomatic and transient to more clinically significant and long-lasting cardiac events. It is critical however, that concerns about potential CV damage resulting from anticancer therapies should be weighed against the potential benefits of cancer therapy, including benefits in overall survival. CV disease in patients with cancer is complex and treatment needs to be individualised. The scope of cardio-oncology is wide and includes prevention, detection, monitoring and treatment of CV toxicity related to cancer therapy, and also ensuring the safe development of future novel cancer treatments that minimise the impact on CV health. It is anticipated that the management strategies discussed herein will be suitable for the majority of patients. Nonetheless, the clinical judgment of physicians remains extremely important; hence, when using these best clinical practices to inform treatment options and decisions, practitioners should also consider the individual circumstances of their patients on a case-by-case basis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to the cumulative cisplatin dose, peak drug exposure, young age at treatment, co-administration of other ototoxic drugs and others are well-defined risk factors for more severe auditory damage 167,168,169 .”
From Osteosarcoma (2022) · cites this paper as [167]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
Self-citation2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Self-citationSlamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Self-citationStone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Cancer treatment and survivorship statistics, 2016
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
Cited by
Sorted by citations
Items 701–800 of 999
Abboud, K., Umoru, G., Trachtenberg, B. H., & Ajewole, V. B. (2024) · Cardio-Oncology · doi:10.1186/s40959-024-00221-5 · Cited by 2
Coronary Artery Calcium for Cardiovascular Risk Estimation in Patients With Cancer
Karády, J., & Ferencik, M. (2023) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.123.015172 · Cited by 2
The Role of GLP-1 Receptor Agonists in Managing Cancer Therapy-Related Cardiac DysfunctionPreprint
Vignarajah, A., Kim, S., Albliwi, M., Ahn, H. M., Izda, A., Naffa, F., Vigneswaramoorthy, N. A., Barot, S. V., & Shah, G. V. (2025) · medRxiv · doi:10.1101/2025.01.02.25319923 · Cited by 2
Molecular imaging of free radicals for anthracycline-induced cardiotoxicity: See the burn?
Hyafil, F., Mirabel, M., & Tavitian, B. (2022) · PubMed · doi:10.1007/s12350-020-02254-6 · Cited by 1
Cardiac risk stratification of breast cancer patients in a cardio-oncology clinic
Doukas, P. G., Patel, R. N., Venkatesh, V., Khan, S. S., Baldridge, A. S., & Akhter, N. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06353-x · Cited by 1
A kardiotoxicitás definíciójának evolúciója és újraértelmezése
Czuriga, D., Drobni, Z. D., & Pozsonyi, Z. (2023) · Cardiologia Hungarica · doi:10.26430/chungarica.2023.53.2.89 · Cited by 1
Cardiotoxicities of Non-Chemotherapeutic Metastatic Breast Cancer Treatments
Soltani, M., Sokoloff, L. J., & Fradley, M. G. (2023) · Current Oncology Reports · doi:10.1007/s11912-023-01427-z · Cited by 1
Self-citationHeartbreaker: Detection and prevention of cardiotoxicity in hematological malignancies
Vakilpour, A., Lefebvre, B., Lai, C., & Scherrer‐Crosbie, M. (2023) · Blood Reviews · doi:10.1016/j.blre.2023.101166 · Cited by 1
Roos, A., & Edgren, G. (2024) · The American Journal of Medicine · doi:10.1016/j.amjmed.2024.03.005 · Cited by 1
Cardiovascular interventions in patients with active and advanced malignancy: An updated review
Waqar, F., Sultan, A., Bathija, R. R., Mehmoodi, A., & Malik, J. (2024) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.55729/2000-9666.1369 · Cited by 1
RESEARCH ON THE VARIATIONAL METHOD OF PROCESSING SIGNAL VARIABILITY OF HEART RHYTHM
Qarayeva, Y. R. S. Q. S. (2024) · PIRETC-Proceeding of The International Research Education & Training Centre · doi:10.36962/piretc30012024-27 · Cited by 1
Merolillo, K., Solari, M. I. G., Cohen, T. P., Lutz, A., de Carvalho, P., Cañellas, F., Rech, D. I., de Carvalho, O., Zelmanowicz, A. D. M., Lehnen, A. M., et al. (2024) · Cardio-Oncology · doi:10.1186/s40959-024-00258-6 · Cited by 1
Zhang, J., Li, X., Li, D.-X., Zhang, Z.-H., Hu, L., Sun, C.-X., Zhang, X., Wu, M., & Liu, L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117720 · Cited by 1
Küresel İklim Değişikliğinin Jinekolojik Kanserler Üzerine Etkisi: Derleme
Küçükkaya, B., & Temiz, M. (2024) · Bilecik Şeyh Edebali Üniversitesi Sağlık Bilimleri Fakültesi Dergisi · doi:10.61535/bseusbfd.1505089 · Cited by 1
Comprehensive Strategies to Address Radiation-Induced Restrictive Cardiomyopathy
Akeel, M. A., Notta, S., Akeel, W. A., Alhuneafat, L., Ramu, V. K., & Jbara, M. H. (2025) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2024.0058 · Cited by 1
Jeon, M. H., DiSipio, T., Wilson, L. F., Garvey, G., & Diaz, A. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.102903 · Cited by 1
Management of Stable Coronary Artery Disease and Acute Coronary Syndrome in Patients with Cancer
Desai, S., Aziz, M. K., Marmagkiolis, K., Çilingiroğlu, M., Iliescu, C., & Ynalvez, L. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02214-x · Cited by 1
Riahi, F., Tooyserkani, S. H., Sadeghian, A., Azizollahi, S., Sourani, A., Alaei, M., Khansari, M., Hashemi, M. G., Fesharaki, S., Tabatabaei, S. A. D., et al. (2025) · Clinical and Translational Imaging · doi:10.1007/s40336-025-00703-1 · Cited by 1
Medical society guidelines in cardio-oncology
Cullinane, R. R., Hamid, A. B., Malatches, B., EL-MAIS, I., Dauccia, C., Agostinetto, E., Price, E. B., Rickards, J., Bergom, C. R., de Azambuja, E., et al. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29829-5.00013-x · Cited by 1
Iron Metabolism in Cardiovascular Disease
Kalousdian, A., Ardehali, M. M., & Ardehali, H. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-92033-2_15 · Cited by 1
Machado, B. B., Biolo, A., Júnior, F. P., Schroeder, A. D. Q., & Saffi, M. A. L. (2025) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552251358183 · Cited by 1
Moghaddam, A. A., Fazaeli, S. H., & Kamandi, M. (2025) · Health Science Reports · doi:10.1002/hsr2.71031 · Cited by 1
Serum Proteomics of Ribociclib‐Mediated Cardiovascular Toxicity: An Exploratory Case–Control Study
Fiste, O., Samiotaki, M. K., Manios, E. D., Trika, C. O., Liacos, C., Dimitrakakis, C., Dimopoulos, M. A., Gavriatopoulou, M., & Zagouri, F. (2025) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.70021 · Cited by 1
Cardiac imaging in oncology: the detection of cardiotoxicity
Negishi, T., Miyazaki, S., Park, J., & Negishi, K. (2025) · Heart · doi:10.1136/heartjnl-2024-323864 · Cited by 1
Zhou, Y., Lin, H., Huang, C., Xu, Y., Li, Y., Xia, C., Zhang, Q., Han, Y., Ou, X., & Chen, Y. (2025) · Cardio-Oncology · doi:10.1186/s40959-025-00377-8 · Cited by 1
Cheng, S., Deng, M., Qi, L., Li, F., Chen, J., Cui, S., Wang, Y., Liu, J., Fan, Y., Xie, L., et al. (2025) · Radiology and Oncology · doi:10.2478/raon-2025-0043 · Cited by 1
Atrial Fibrillation and Cancer
Grewal, U. S., Byer, S. H., Mahajan, S., Sheth, A. R., Beedupalli, K., Fradley, M. G., Yang, E. H., Russo, A. M., Asnani, A. H., & Dominic, P. S. (2025) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2025.09.044 · Cited by 1
Self-citationLim, Y., Lee, Y. J., Ha, I., & Lee, Y. (2025) · PLoS ONE · doi:10.1371/journal.pone.0335083 · Cited by 1
Zeng, Z., Li, J., Luo, R., & Lan, X. (2025) · Postgraduate Medicine · doi:10.1080/00325481.2025.2602219 · Cited by 1
Role of Perindopril in Mitigating Doxorubicin’s Vascular Toxicity in a Rat Model
Marada, A., Stračina, T., Marhefka, F., Šůstková, L., Nádeníček, J., Smutná, J., Scheer, P., Hložková, J., Hendrych, M., Studenik, C. R., et al. (2026) · Cardiovascular Toxicology · doi:10.1007/s12012-026-10092-0 · Cited by 1
Yao, R., Huang, J., Shan, X., Li, R., Chen, H., Zhao, P., Lu, R., & Zhang, C. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121398 · Cited by 1
Cardiac Surgery in Cancer Patients: Clinical Dilemmas and Decision-Making Challenges
Keramida, K., Tsekoura, D., Roubelakis, A., Michalopoulou, H., & Androutsopoulou, V. A. (2026) · Cancers · doi:10.3390/cancers18050748 · Cited by 1
THE EFFECTIVENESS OF TRIMETAZIDINE THERAPY FOR CHRONIC HEART FAILURE INDUCED BY ANTHRACYCLINE
Shilov, S. N., Николаевна, Б. Е., Таировна, Б. Е., Popova, A. A., Аркадьевна, Г. И., Teplyakov, A. T., Grakova, E. V., Kopeva, K. V., & Vorozhtsova, I. N. (2025) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2025-14-5-178-189 · Cited by 1
Tana, M., Piccinini, R., Pinterpe, G., Porreca, E., Berardi, R., & Tana, C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27072973 · Cited by 1
Gao, M., Liu, X., Wu, L., Jiang, Y., Yu, J., & Zhang, Y. (2026) · Human Mutation · doi:10.1155/humu/8506248 · Cited by 1
Lin, R., Li, Y., Liu, X., Meng, F., Wang, X., 蒋田南, 蒋田南, Liu, C., Jin, S., Liu, T., et al. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.05.320 · Cited by 1
Dent, S., Nadler, M. B., Blaes, A., Iqbal, A., Ayettey, H. N. G., Alvarez-Cardona, J. A., Chan, A., Koh, E., Mascuñano, R. C., George, M. A., et al. (2026) · Cardio-Oncology · doi:10.1186/s40959-026-00481-3 · Cited by 1
Self-citationAtkins, K. M., Walls, G., Nikolova, A., Ferrall, J., Oorloff, M., Bychowski, J., Kolb, K., Karlstaedt, A., Mitchell, J. D., Mak, R. H., et al. (2026) · JACC CardioOncology · doi:10.1016/j.jaccao.2026.04.009 · Cited by 1
Self-citationXu, L., Wu, H., Wu, C., & Xu, Y. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108316 · Cited by 3
Misra, S., Bansal, S., Lal, P., Khanna, R., Kapoor, A., & Kumar, S. (2026) · Future Cardiology · doi:10.1080/14796678.2026.2692601 · Cited by 1
Tsiamis, N., Toulgaridis, F., Stefanou, E., Tountas, C., Tsitsinakis, G., Ballas, E., Maurogenis, I., Kitsiou, A., & Kole, C. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.107051 · Cited by 2
Radiomics for the Detection and Prediction of Cancer Therapy-Related Cardiotoxicity
Kandala, A., Rai, A., Penumaka, R. R., Wilcox, N. S., Lefebvre, B., Bravo, P. E., & Fradley, M. G. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102942 · Cited by 1
Self-citationDowsing, B., Dehbi, H., Andrés, M. S., Chung, R., Oashou, A., Wilson, J. M., Hussein, I., Meredith, B., Pierce, I., Ahmed, S., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag707 · Cited by 2
Self-citationTirinescu, R., Pah, A.-M., Tirinescu, A., Mateescu, D.-M., & Mureșan, C.-O. (2026) · Medicina · doi:10.3390/medicina62091664 · Cited by 1
Biomarkers with Potential Predictive Value for Cardiotoxicity in Anticancer Treatments
Yang, W., & Zhang, M. (2021) · Chinese Medical Sciences Journal · doi:10.1016/s1001-9294(22)00011-6 · Cited by 1
Jouglar, E., Doyen, J., & Supiot, S. (2020) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2020.05.010 · Cited by 1
One size does not fit all: Also true for cardio-oncology
Mendes, L. (2021) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2021.04.002 · Cited by 1
Radiotherapy-induced Cardiotoxicity After the Treatment of Pulmonary and Mediastinal Solid Tumors
Saynak, M. (2022) · Turkish Journal of Oncology · doi:10.5505/tjo.2022.s1004 · Cited by 1
Telehealth consultations in cardio-oncology
Potievskaya, V. I., Kononova, E. V., Shaputko, N. V., Raushkin, D. A., Gameeva, E. V., Alekseeva, G. S., & Каприн, А. Д. (2022) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2022-3164 · Cited by 1
Kalsi, M., Marsden, P., & Sharma, N. (2022) · Heart Lung and Circulation · doi:10.1016/j.hlc.2022.06.105 · Cited by 1
Farhan, H. A., Yaseen, I. F., Alomar, M., Lenihan, D. J., Dent, S. F., & Lyon, A. R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.979631 · Cited by 1
Self-citationIljovska, M., Lazareva, E., Smichkoska, S., Klisarovska, V., Stojkovski, I., Petkovska, G., & Mitreski, N. (2022) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh220308113i · Cited by 1
The nurse's role in the care of the cardiotoxicities generated by chemotherapy administration
Teixeira, T. M., Lordeiro, N. P. F., da Silva, R. C., & Godinho, L. (2023) · Seven Editora eBooks · doi:10.56238/colleinternhealthscienv1-066 · Cited by 1
Chemotherapy-Induced Cardiotoxicity in Cancer Treatment: Mechanisms and Its Prevention
Osataphan, N., Leemasawat, K., Phrommintikul, A., Chattipakorn, S. C., & Chattipakorn, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_344-1 · Cited by 1
Buege, M. J., Drill, E. N., Horwitz, S. M., LeVoir, A., Pak, T., Peterson, T. J., Dao, P. H., & Matasar, M. J. (2023) · European Journal Of Haematology · doi:10.1111/ejh.13971 · Cited by 1
The role of artificial intelligence in cardio-oncology: present and future: A review
Buziashvili, Y. I., Уметовна, А. Э., Фаатовна, Т. Э., & Рустамджонович, А. Ф. (2023) · Consilium Medicum · doi:10.26442/20751753.2023.1.202095 · Cited by 3
Wang, Y., McCarthy, A. L., & Tuffaha, H. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-07819-y · Cited by 1
Ivanova, M. I., Матякин, Г. Г., Иванов, В. М., Коваленко, А. Л., & Ivanova, O. V. (2023) · P A Herzen Journal of Oncology · doi:10.17116/onkolog20231203142 · Cited by 1
Trastuzumab-induced cardiotoxicity: a review
Lapka, M. (2023) · Klinická farmakologie a farmacie · doi:10.36290/far.2023.011 · Cited by 1
Dyrbuś, M., Skoczylas, I., Majsnerowska, A., Gąsior, M., & Tajstra, M. (2023) · Nowotwory Journal of Oncology · doi:10.5603/njo.96405 · Cited by 1
Cvetković, Z., Marković, O., & Mitrović, M. (2023) · Srpski medicinski casopis Lekarske komore · doi:10.5937/smclk4-45065 · Cited by 1
Right Ventricle Toxicity in Cancer Treatment: A Focused Review On Cardiac Imaging
Sanadgol, G., Samimi, S., Shirini, D., Nakhaei, P., Mohseni, M., & Alizadehasl, A. (2023) · Future Cardiology · doi:10.2217/fca-2022-0024 · Cited by 1
Hadžibeganović, A., & Koprić, D. (2023) · Acta Medica Academica · doi:10.5644/ama2006-124.417 · Cited by 1
Concealed Inherited Cardiomyopathies Detected in Cardio-Oncology Screening
Lorca, R., Pascual, I., Fernández, M., Álvarez‐Velasco, R., Colunga, S., Muñiz, M., Izquierdo, M. M., Fernández, Y., Esteban, E., Gómez, J., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010002 · Cited by 1
Cardioprotection Using Doxorubicin: The Role of Dexrazoxane
Krone, R. J., Merchant, A., & Mitchell, J. D. (2024) · Pharmaceutical science. · doi:10.5772/intechopen.1004240 · Cited by 1
Self-citationNakatsuma, K., Ozasa, N., Ohno, M., Ishiguro, H., Minami, M., Nishi, E., Toi, M., Ono, K., & Kimura, T. (2024) · Journal of Cardiology · doi:10.1016/j.jjcc.2024.03.005 · Cited by 1
Hassan, M. S., Attia, W. M., & Khalil, E. E. (2024) · International Journal of Medical Arts · doi:10.21608/ijma.2023.226629.1755 · Cited by 1
Anakwue, R. C., Anakwue, A.-M. C., & Ekwe, E. (2024) · Annals of Clinical and Biomedical Research · doi:10.4081/acbr.2024.490 · Cited by 1
How to utilize current guidelines to manage patients with cancer at high risk for heart failure
Bloom, M. W., Alvarez-Cardona, J. A., Ganatra, S., Barac, A., Pusic, I., Lenihan, D. J., & Dent, S. F. (2024) · Cardio-Oncology · doi:10.1186/s40959-024-00259-5 · Cited by 1
Self-citationSharma, S., Lal, R., & Kumar, B. A. (2024) · Applied Computer Science · doi:10.35784/acs-2024-33 · Cited by 1
A minimalist cardio-oncology service: A personal experience from Wales
Riaz, M. H., Barrington, C., & Ionescu, A. A. (2024) · Romanian Journal of Cardiology · doi:10.2478/rjc-2024-0018 · Cited by 1
A Primer on the Evolving Subspecialty of Onco-Electrophysiology
Nettlefold, C., Chakraborty, P., Al-Shaheen, A., Denham, N. C., Kakarla, J., Burg, M., Hayashi, T., Ahmed, I., & Nanthakumar, K. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.11.005 · Cited by 1
Cardiotoxicity in breast cancer – Are we getting to the heart of the matter?
Steenkamp, Z., Sherriff, A., & van Rooyen, C. (2024) · South African Journal of Oncology · doi:10.4102/sajo.v8i0.297 · Cited by 1
Sunaga, T., Okada, T., Iso, Y., Ebato, M., Toshida, T., Nawata, S., Suzuki, H., & Kogo, M. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15204 · Cited by 1
Redefining the role of anthracyclines in early breast cancer treatment
Marta, G. N., & Piccart, M. J. (2025) · Academia oncology. · doi:10.20935/acadonco7516 · Cited by 1
Evaluation of left atrial strain changes in patients with breast cancer after anthracycline therapy
Mokadem, M. E., Shaaban, S. M., & Amin, O. A. (2025) · The Egyptian Heart Journal · doi:10.1186/s43044-024-00591-2 · Cited by 1
Tu, Y., Kou, X.-Y., Zhou, J., Zhang, X. Z., Cao, L., Zheng, X. Y., Li, J., Feng, X., Xiao, Z., & Chen, J. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0108 · Cited by 1
Charbonnel, C. (2020) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2020.09.003 · Cited by 1
Figueiras-Graillet, L. M., García-Jiménez, Y., Rosas-Munive, E., Escobar, P., Sierra-Galán, L. M., Vásquez-Ortiz, Z. Y., Ruiz-Gastélum, E., Ancona-Vadillo, A. E., Puente-Barragán, A. C., & Parra-Machuca, M. G. (2020) · Cardiovascular and Metabolic Science · doi:10.35366/95587 · Cited by 2
Selección de lo mejor del año 2020 en imagen cardiovascular
Martínez‐Monzonís, A., Barreiro‐Pérez, M., Li, C.-I., Jiménez‐Borreguero, L. J., Guzmán, G., Fernández‐Golfín, C., Aguadé‐Bruix, S., & López‐Fernández, T. (2020) · REC CardioClinics · doi:10.1016/j.rccl.2020.10.010 · Cited by 1
Mingrone, G., Moia, E. C., Delsignore, E., Demicheli, G., Destefanis, P., Forno, D., Tos, G. G., Luciano, A., Pinna, G., Ravera, L., et al. (2021) · Hearts · doi:10.3390/hearts2010006 · Cited by 1
Dysfunkcja węzła zatokowego jako późne powikłanie leczenia chłoniaka Hodgkina
Daniluk, P., Sławiński, G., Nabiałek-Trojanowska, I., & Lewicka, E. (2020) · Folia Cardiologica · doi:10.5603/fc.2020.0062 · Cited by 1
Prus, Y. A., Ansheles, A. A., & Сергиенко, И. В. (2021) · Kardiologiia · doi:10.18087/cardio.2021.1.n1376 · Cited by 1
Cidón, E. U., Hickish, T., & Alonso, P. (2021) · Open Science Journal · doi:10.23954/osj.v6i1.2719 · Cited by 1
Một số ảnh hưởng trên chức năng thất trái ở các bệnh nhân ghép tế bào gốc điều trị bệnh máu ác tính
Hiền, M. T. T., Bảng, Đ. K., & Tùng, N. T. (2021) · Tạp chí Nghiên cứu Y học · doi:10.52852/tcncyh.v140i4.147 · Cited by 1
Hou, P.-Y., Wu, Y., Wu, L.-J., Hsieh, C.-H., Hsu, C., Kuo, D., Lu, Y.-F., Tien, H., Yeh, H.-P., Shueng, P., et al. (2021) · Therapeutic Radiology and Oncology · doi:10.21037/tro-21-20 · Cited by 1
Vascular Toxicity and Cardiotoxicity of Cancer Treatment
Macedo, A. V. S., Silva, C. M. P. D. C., Pellegrino, L. B., & Felipe, P. T. (2022) · Springer eBooks · doi:10.1007/978-3-030-97687-3_12 · Cited by 1
Fonseca, T., Pessoa, V., Miranda, D., Martins, D., Costa, N., & Lima, H. (2022) · Współczesna Onkologia · doi:10.5114/wo.2022.120639 · Cited by 1
Rango, E., Maria, S. D., Zamperini, C., Poggialini, F., Crespan, E., Perini, C., Sabetta, S., Saponara, S., Fusi, F., Maga, G., et al. (2023) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-023-02836-x · Cited by 1
Airo, A. A., & Sunela, K. L. (2023) · Acta Oncologica · doi:10.1080/0284186x.2023.2245551 · Cited by 1
The evolution of defining and the reinterpretation of cardiotoxicity
Czuriga, D., Drobni, Z. D., & Pozsonyi, Z. (2023) · Cardiologia Croatica · doi:10.15836/ccar2024.169 · Cited by 1
Anthracycline-induced cardiomyopathy: Is there a new light at the end of the tunnel?
Fradley, M. G., & Olshansky, B. (2021) · Heart Rhythm O2 · doi:10.1016/j.hroo.2021.10.008 · Cited by 1
Self-citationMore Data to Support a Cardiac-Oncologic Partnership
Krone, R. J., & Tine, B. A. V. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2023.01.002 · Cited by 1
Self-citationJoshi, A. A., & Aziz, R. M. (2023) · Research Square · doi:10.21203/rs.3.rs-2896430/v2 · Cited by 1
Ho, C. C., Wu, S.-L., Tsai, H., & Chou, C. (2024) · Research Square · doi:10.21203/rs.3.rs-4389888/v1 · Cited by 1
Shwetha, N. N., Gangadhar, N., Neelagar, M. B., Sangeetha, N., & Dalal, V. B. (2024) · doi:10.1002/9781119847717.ch8 · Cited by 1
Immune checkpoint inhibitor associated neurotoxicity: Much more than meets the eye
Raibagkar, P. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.02.007
Partnering Teams to Optimize the Care of Patients With HER2-Positive Breast Cancer
Mayer, E. L. (2020) · JACC CardioOncology · doi:10.1016/j.jaccao.2020.05.001
Prävention und Therapie der Kardiotoxizität
Braumann, S., & Pfister, R. (2020) · Im Focus Onkologie · doi:10.1007/s15015-020-2366-6
Tandar, A., Catino, A., & Sharma, V. (2020) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2020.11.006
Metadata
- Authors
- Curigliano, G., Lenihan, D., Fradley, M., Ganatra, S., Barac, A., Blaes, A., Herrmann, J., Porter, C., Lyon, A. R., Lancellotti, P., Patel, A., DeCara, J., Mitchell, J., Harrison, E., Moslehi, J., Witteles, R., Calabro, M. G., Orecchia, R., de Azambuja, E., Zamorano, J. L., Krone, R., Iakobishvili, Z., Carver, J., Armenian, S., Ky, B., Cardinale, D., Cipolla, C. M., Dent, S., & Jordan, K.
- Affiliations
- University of Milan (IT)
- Washington University Medical Center (US)
- University of South Florida (US)
- Lahey Hospital and Medical Center (US)
- Georgetown University (US)
- University of Minnesota (US)
- Mayo Clinic (US)
- University of Kansas Medical Center (US)
- Royal Brompton Hospital (GB)
- Centre Hospitalier Universitaire de Liège (BE)
- University of Chicago (US)
- Vanderbilt University (US)
- Stanford Medicine (US)
- European Institute of Oncology (IT)
- Hospital Universitario Ramón y Cajal (ES)
- Washington University in St. Louis (US)
- Tel Aviv University (IL)
- Hospital of the University of Pennsylvania (US)
- City Of Hope National Medical Center (US)
- University of Pennsylvania (US)
- Duke University (US)
- Heidelberg University (DE)
- ORCID
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 31
- Issue
- 2
- Pages
- 171-190
- ISSN
- 0923-7534 (ISSN-L)
- PMC
- PMC8019325
- OpenAlex
- W2999536665
- Cited by
- 1,031
- References
- 221
- Citations by year
- 2026: 108 · 2025: 152 · 2024: 168 · 2023: 189 · 2022: 188 · 2021: 143 · 2020: 83
- FWCI
- 93.28
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Annals of Oncology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- ORBi (University of Liège) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- HF
- Genentech
- Amgen
- Servier
- Pfizer
- Bristol-Myers Squibb
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac tumors and thrombi
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Keywords
- cardio-oncology, cardiotoxicity, cancer therapy, heart failure, cardiovascular screening, cardiovascular monitoring, novel cancer therapies, cardiovascular disease in cancer patients
- MeSH terms
- Antineoplastic Agents, Heart Diseases, Humans, Medical Oncology, Neoplasms, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
